{"doc_id": 0, "doc": {"person_id": 115967197, "visit_occurrence_id": 109834825, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-10-09 00:00:00", "visit_end_datetime": "2017-10-09 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 92, "patient_first_visit_date": "2012-10-05 14:12:00", "patient_last_visit_date": "2021-03-30 16:05:00", "end_obs_date": "2018-10-09", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 7, "cumulated_visit_num": 7, "cumulated_approximate_token_count": 4962, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6d2f9f268c6962869346308bbd248a7d0d974b3a3874000cc068eb9db775e4a9", "prompt_hash": "605ac27712766e5f41abd84080604ee43ecd9c799ff1872465255e62463bee4b", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967248, "visit_occurrence_id": 83162915, "death_date": null, "visit_concept_name": "Emergency Room Visit", "visit_start_datetime": "2016-03-02 21:37:00", "visit_end_datetime": "2016-03-02 22:37:00", "visit_length_in_hours": 1.0, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 152, "patient_first_visit_date": "2008-06-25 16:50:00", "patient_last_visit_date": "2017-10-04 22:47:00", "end_obs_date": "2017-03-02", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 3, "cumulated_visit_num": 3, "cumulated_approximate_token_count": 1260, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-06-25 16:50:00, ended at 2008-06-25 23:57:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-09-04 10:34:00, ended at 2011-09-04 16:48:00\nThe patient in this visit was 59 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.02 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Dizziness and giddiness\n- Abnormal results function studies of central nervous system\n- Disorder of brain\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-09-04\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-10-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-06-25 16:50:00, ended at 2008-06-25 23:57:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-09-04 10:34:00, ended at 2011-09-04 16:48:00\nThe patient in this visit was 59 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.02 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Dizziness and giddiness\n- Abnormal results function studies of central nervous system\n- Disorder of brain\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-09-04\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-10-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a7aaf8e246a3799cc81c0540fd814dc124fa861f0b2def151e70218d38d14ed1", "prompt_hash": "52995d4ed8c9ad304cb368ae211b6b14ab7e29509de021fd97a4c4747e1e71e3", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115967631, "visit_occurrence_id": 150348663, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2020-02-09 08:42:20", "visit_end_datetime": "2020-02-09 09:51:28", "visit_length_in_hours": 1.1522222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2016-06-20 10:15:08", "patient_last_visit_date": "2022-04-17 13:33:28", "end_obs_date": "2021-02-08", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 15, "cumulated_visit_num": 15, "cumulated_approximate_token_count": 3258, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5cefe9f6ed6138e55c0ad34b9fc0be2eded1bcdcfd679bf96c62573b41e4726e", "prompt_hash": "0e22e39e8901bc9c5ef8329632635d10369bcc9d94aafe9ed224898b693f12f0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115967648, "visit_occurrence_id": 180405753, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2021-06-06 00:00:00", "visit_end_datetime": "2021-06-06 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2019-12-21 00:00:00", "patient_last_visit_date": "2023-01-16 00:00:00", "end_obs_date": "2022-06-06", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 83, "cumulated_visit_num": 83, "cumulated_approximate_token_count": 13523, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 11:43:13, ended at 2019-12-21 13:57:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2019-03-04, presumably until 2020-12-16, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:00:00, ended at 2019-12-21 14:42:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Persistent atrial fibrillation\n- Chronic atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:43:00, ended at 2019-12-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-29 07:00:00, ended at 2020-01-29 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Ventricular tachycardia\n- Atrial flutter\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily Start on 05/10 and continue until prescription is completed.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (1 g total) by mouth 4 times a day Start medication on 05/22/2020 and continue until completed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-18 10:42:00, ended at 2020-05-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)\n\n### Condition\n- Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 12:43:14, ended at 2020-05-19 13:10:48\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-20, presumably until 2020-12-11, with intended 0 refill(s). Instructions: take 75 mg by mouth 4 times a day \n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2020-03-27, presumably until 2021-06-05, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-21 10:02:38, ended at 2020-05-21 10:02:53\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- mepivacaine hydrochloride 20 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hypothyroidism\n- Chronic kidney disease stage 2\n- Persistent atrial fibrillation\n- Chronic kidney disease due to hypertension\n- Prediabetes\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- remifentanil 2 MG Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 05:31:00, ended at 2020-05-25 11:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Activated clotting time (ACT) of Blood by Coagulation assay: 392 (second)\n- Body height: 5' 10.276\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 79.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.38 (unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 14.50 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Prothrombin time (PT): 17.6 (second)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Collection of venous blood by venipuncture\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac \n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Disorder of cardiovascular system\n- Lumbar radiculopathy\n- Metabolic syndrome X\n- Essential hypertension\n- Hypothyroidism\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Paroxysmal atrial fibrillation\n- Primary diagnosis: Persistent atrial fibrillation\n- Abnormal results of cardiovascular function studies\n- Chronic kidney disease stage 2\n- Prediabetes\n- Electrocardiogram abnormal\n- Polyp of colon\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-05-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- benazepril hydrochloride 40 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-08-31, with intended 0 refill(s). Instructions: inject 1 mg/kg subcutaneous (under the skin) daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-05-25\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-06-08, with intended 3 refill(s). Instructions: take 400 mg by mouth 2 times a day for 7 days, THEN 200 mg 2 times a day for 7 days, THEN 200 mg daily.\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.91 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-05-27, presumably until 2020-09-22, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-29, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-05-29, presumably until 2020-05-29, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-08-15, with intended 11 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-09 11:25:00, ended at 2020-06-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH ONCE DAILY START ON 05/10 AND CONTINUE UNTIL PRESCRIPTION IS COMPLETED.\n- sucralfate 1000 MG Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY START MEDICATION ON 05/22/2020 AND CONTINUE UNTIL COMPLETED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-13 06:00:00, ended at 2020-06-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 08:52:48, ended at 2020-06-16 10:12:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Thyroglobulin Ab [Units/volume] in Serum or Plasma: 2.6 (international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 255 (picogram per milliliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 7 (international unit per milliliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.6 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 12.770 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.11 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 10.25\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Hyperlipidemia\n- Vitamin B deficiency\n- Vitamin D deficiency\n- Atrial fibrillation\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-20 11:30:00, ended at 2020-06-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n\n### Condition\n- Pulmonary function studies abnormal\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-01 00:00:00, ended at 2020-07-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-04 00:00:00, ended at 2020-07-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-07 00:00:00, ended at 2020-07-07 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-08 00:00:00, ended at 2020-07-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-20 14:35:26, ended at 2020-07-20 14:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Prediabetes\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-08-15, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 0.5 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-30 10:00:00, ended at 2020-08-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-31 10:18:59, ended at 2020-08-31 11:01:03\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2020-08-31, presumably until 2021-09-05, with intended 12 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-22 09:31:38, ended at 2020-09-22 09:59:53\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-09-22, presumably until 2021-03-30, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-30 07:30:00, ended at 2020-09-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n- Persistent atrial fibrillation\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-16 12:57:09, ended at 2020-11-16 13:31:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Long QT syndrome\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-18 11:00:00, ended at 2020-11-18 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-21 00:00:00, ended at 2020-11-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-01 00:00:00, ended at 2020-12-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-01 09:02:00, ended at 2020-12-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-12-16, presumably until 2021-03-09, with intended 0 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-19 10:19:56, ended at 2020-12-19 10:30:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism caused by drug\n- Prediabetes\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-17 09:59:16, ended at 2021-01-17 11:01:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Paroxysmal atrial fibrillation\n- Coronary atherosclerosis\n- Blood glucose abnormal\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-17, presumably until 2021-03-09, with intended 11 refill(s). Instructions: take 12.5 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-20 06:45:00, ended at 2021-01-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2021-02-09, presumably until 2021-03-03, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-13 00:00:00, ended at 2021-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Complete atrioventricular block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-15 08:30:00, ended at 2021-02-15 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-22 08:32:00, ended at 2021-02-22 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-03, presumably until 2021-03-10, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-03 15:11:00, ended at 2021-03-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-08 00:00:00, ended at 2021-03-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, started on 2021-03-09, presumably until 2021-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-03-10, presumably until 2021-03-20, with intended 1 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-20 00:00:00, ended at 2021-03-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-20, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth as directed (Take 1mg in the morning and 2mg at night)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2021-03-30, presumably until 2021-11-20, with intended 3 refill(s). Instructions: TAKE 1 TAB (50 MCG TOTAL) BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-04 00:00:00, ended at 2021-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-04, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-19 00:00:00, ended at 2021-04-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-19, presumably until 2021-06-05, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every morning AND 1.5 Tabs (3 mg total) Daily at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-19 11:34:11, ended at 2021-04-19 12:12:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-20 06:15:00, ended at 2021-04-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-25 10:16:13, ended at 2021-04-25 11:00:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-04-25, presumably until 2021-08-21, with intended 11 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-26 16:08:55, ended at 2021-04-26 16:09:05\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Prediabetes\n- Paroxysmal atrial fibrillation\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-28, presumably until 2021-04-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 07:16:00, ended at 2021-04-28 11:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Hypothyroidism\n- Rheumatic tricuspid valve regurgitation\n- Atrial fibrillation\n- Typical atrial flutter\n- Atrial flutter\n- Atrial premature complex\n- Persistent atrial fibrillation\n- Lumbar radiculopathy\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Ventricular premature complex\n- Atherosclerosis of coronary artery without angina pectoris\n- Electrocardiogram abnormal\n- Essential hypertension\n- Prediabetes\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-05-14 14:29:00, ended at 2021-05-14 18:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Tachycardia\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-14\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-16, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-16 00:00:00, ended at 2021-05-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-16, presumably until 2021-06-29, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth 2 times a day as needed For AFib episodes\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-23 00:00:00, ended at 2021-05-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-06-13, presumably until 2021-11-28, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily Start 4 days pre-procedure, and continue 30 days after, no refills. First dose 08/14/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-25 00:00:00, ended at 2021-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-31 13:29:00, ended at 2021-05-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-02 00:00:00, ended at 2021-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 11:43:13, ended at 2019-12-21 13:57:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2019-03-04, presumably until 2020-12-16, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:00:00, ended at 2019-12-21 14:42:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Persistent atrial fibrillation\n- Chronic atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-21 14:43:00, ended at 2019-12-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-28 00:00:00, ended at 2020-01-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-29 07:00:00, ended at 2020-01-29 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Ventricular tachycardia\n- Atrial flutter\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily Start on 05/10 and continue until prescription is completed.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-22, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (1 g total) by mouth 4 times a day Start medication on 05/22/2020 and continue until completed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-18 10:42:00, ended at 2020-05-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)\n\n### Condition\n- Persistent atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 12:43:14, ended at 2020-05-19 13:10:48\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-04-20, presumably until 2020-12-11, with intended 0 refill(s). Instructions: take 75 mg by mouth 4 times a day \n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2020-03-27, presumably until 2021-06-05, with intended 0 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-21 10:02:38, ended at 2020-05-21 10:02:53\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronavirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- mepivacaine hydrochloride 20 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hypothyroidism\n- Chronic kidney disease stage 2\n- Persistent atrial fibrillation\n- Chronic kidney disease due to hypertension\n- Prediabetes\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- remifentanil 2 MG Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-24, presumably until 2020-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-24, presumably until 2020-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-24 05:31:00, ended at 2020-05-25 11:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Activated clotting time (ACT) of Blood by Coagulation assay: 392 (second)\n- Body height: 5' 10.276\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 79.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.38 (unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 14.50 (micro-international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Prothrombin time (PT): 17.6 (second)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Collection of venous blood by venipuncture\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac \n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Disorder of cardiovascular system\n- Lumbar radiculopathy\n- Metabolic syndrome X\n- Essential hypertension\n- Hypothyroidism\n- Postoperative state\n- Chronic kidney disease due to hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Paroxysmal atrial fibrillation\n- Primary diagnosis: Persistent atrial fibrillation\n- Abnormal results of cardiovascular function studies\n- Chronic kidney disease stage 2\n- Prediabetes\n- Electrocardiogram abnormal\n- Polyp of colon\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-05-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- benazepril hydrochloride 40 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2020-05-25, presumably until 2020-08-31, with intended 0 refill(s). Instructions: inject 1 mg/kg subcutaneous (under the skin) daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-05-25\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-25\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n- amiodarone hydrochloride 400 MG Oral Tablet, through Oral route, started on 2020-05-25, presumably until 2020-06-08, with intended 3 refill(s). Instructions: take 400 mg by mouth 2 times a day for 7 days, THEN 200 mg 2 times a day for 7 days, THEN 200 mg daily.\n- citalopram 10 MG Oral Tablet, through Oral route, started on 2020-05-24, presumably until 2020-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.91 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-05-27, presumably until 2020-09-22, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-29, presumably until 2020-08-31, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-05-29, presumably until 2020-05-29, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-08-15, with intended 11 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-09 00:00:00, ended at 2020-06-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-09 11:25:00, ended at 2020-06-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-11 00:00:00, ended at 2020-06-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH ONCE DAILY START ON 05/10 AND CONTINUE UNTIL PRESCRIPTION IS COMPLETED.\n- sucralfate 1000 MG Oral Tablet, started on 2020-06-13, presumably until 2020-06-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY START MEDICATION ON 05/22/2020 AND CONTINUE UNTIL COMPLETED.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-13 06:00:00, ended at 2020-06-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 08:52:48, ended at 2020-06-16 10:12:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Thyroglobulin Ab [Units/volume] in Serum or Plasma: 2.6 (international unit per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 255 (picogram per milliliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 7 (international unit per milliliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.6 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 12.770 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.11 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 10.25\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Hyperlipidemia\n- Vitamin B deficiency\n- Vitamin D deficiency\n- Atrial fibrillation\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-20 11:30:00, ended at 2020-06-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Respiratory flow volume loop\n\n### Condition\n- Pulmonary function studies abnormal\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-01 00:00:00, ended at 2020-07-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retinal disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-04 00:00:00, ended at 2020-07-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-07 00:00:00, ended at 2020-07-07 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-08 00:00:00, ended at 2020-07-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-20 14:35:26, ended at 2020-07-20 14:50:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Prediabetes\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-08-15, presumably until 2020-12-05, with intended 0 refill(s). Instructions: take 0.5 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-29 00:00:00, ended at 2020-08-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-30 10:00:00, ended at 2020-08-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-31 10:18:59, ended at 2020-08-31 11:01:03\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bradycardia\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2020-08-31, presumably until 2021-09-05, with intended 12 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-22 09:31:38, ended at 2020-09-22 09:59:53\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-09-22, presumably until 2021-03-30, with intended 4 refill(s). Instructions: take 1 Tab (50 mcg total) by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-30 07:30:00, ended at 2020-09-30 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial flutter\n- Persistent atrial fibrillation\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-16 12:57:09, ended at 2020-11-16 13:31:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-18 00:00:00, ended at 2020-11-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Long QT syndrome\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-18 11:00:00, ended at 2020-11-18 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-21 00:00:00, ended at 2020-11-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-01 00:00:00, ended at 2020-12-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-01 09:02:00, ended at 2020-12-01 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-05 00:00:00, ended at 2020-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2020-12-16, presumably until 2021-03-09, with intended 0 refill(s). Instructions: take 1 Tab (200 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-19 10:19:56, ended at 2020-12-19 10:30:47\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism caused by drug\n- Prediabetes\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-17 09:59:16, ended at 2021-01-17 11:01:22\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Paroxysmal atrial fibrillation\n- Coronary atherosclerosis\n- Blood glucose abnormal\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-17, presumably until 2021-03-09, with intended 11 refill(s). Instructions: take 12.5 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-20 06:45:00, ended at 2021-01-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2021-02-09, presumably until 2021-03-03, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-13 00:00:00, ended at 2021-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Complete atrioventricular block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-15 08:30:00, ended at 2021-02-15 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-22 08:32:00, ended at 2021-02-22 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-03 00:00:00, ended at 2021-03-03 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-03, presumably until 2021-03-10, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-03 15:11:00, ended at 2021-03-03 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-08 00:00:00, ended at 2021-03-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, started on 2021-03-09, presumably until 2021-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-10 00:00:00, ended at 2021-03-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-03-10, presumably until 2021-03-20, with intended 1 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-20 00:00:00, ended at 2021-03-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 1 MG Oral Tablet, through Oral route, started on 2021-03-20, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth as directed (Take 1mg in the morning and 2mg at night)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2021-03-30, presumably until 2021-11-20, with intended 3 refill(s). Instructions: TAKE 1 TAB (50 MCG TOTAL) BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-04 00:00:00, ended at 2021-04-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-04, presumably until 2021-04-19, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-19 00:00:00, ended at 2021-04-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2021-04-19, presumably until 2021-06-05, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth every morning AND 1.5 Tabs (3 mg total) Daily at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-19 11:34:11, ended at 2021-04-19 12:12:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-20 06:15:00, ended at 2021-04-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation\n- External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Atrial flutter\n- Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-25 10:16:13, ended at 2021-04-25 11:00:40\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-04-25, presumably until 2021-08-21, with intended 11 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-26 00:00:00, ended at 2021-04-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-26 16:08:55, ended at 2021-04-26 16:09:05\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Prediabetes\n- Paroxysmal atrial fibrillation\n- Essential hypertension\n- Hypothyroidism\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-28, presumably until 2021-04-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-28 07:16:00, ended at 2021-04-28 11:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n\n### Procedure\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Hypothyroidism\n- Rheumatic tricuspid valve regurgitation\n- Atrial fibrillation\n- Typical atrial flutter\n- Atrial flutter\n- Atrial premature complex\n- Persistent atrial fibrillation\n- Lumbar radiculopathy\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n- Ventricular premature complex\n- Atherosclerosis of coronary artery without angina pectoris\n- Electrocardiogram abnormal\n- Essential hypertension\n- Prediabetes\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-05-14 14:29:00, ended at 2021-05-14 18:25:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Tachycardia\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-14\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-14, presumably until 2021-05-16, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-16 00:00:00, ended at 2021-05-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2021-05-16, presumably until 2021-06-29, with intended 0 refill(s). Instructions: take 0.5 Tablets (12.5 mg total) by mouth 2 times a day as needed For AFib episodes\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-23 00:00:00, ended at 2021-05-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-06-13, presumably until 2021-11-28, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily Start 4 days pre-procedure, and continue 30 days after, no refills. First dose 08/14/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-25 00:00:00, ended at 2021-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-31 13:29:00, ended at 2021-05-31 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-02 00:00:00, ended at 2021-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-06 00:00:00, ended at 2021-06-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8bcd6b70cb8efffe2e11d04b49180d1e00130b055ee387b1a6780d0ca59f460f", "prompt_hash": "da9d054d6e4633b013ae16e05dfe65635a40be25ef0862b4477ff04c782f173b", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115967662, "visit_occurrence_id": 74340640, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-05-29 10:01:00", "visit_end_datetime": "2015-05-29 23:59:00", "visit_length_in_hours": 13.966666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 109, "patient_first_visit_date": "2014-04-02 10:22:59", "patient_last_visit_date": "2016-06-18 12:52:51", "end_obs_date": "2016-05-28", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 12, "cumulated_visit_num": 12, "cumulated_approximate_token_count": 3578, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3d3bacee159ce66419ffd8ed1625c63eea52252f6490890d91e394330c42c62a", "prompt_hash": "6275d935e3270b4216072df75e5f5ee4270e4d382dcf0eeb16d840ebe8e28dc2", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115967699, "visit_occurrence_id": 172123964, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-01-26 00:00:00", "visit_end_datetime": "2021-01-26 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n", "approximate_token_count": 130, "patient_first_visit_date": "2018-07-27 08:09:53", "patient_last_visit_date": "2022-11-11 10:16:14", "end_obs_date": "2022-01-26", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 38, "cumulated_visit_num": 38, "cumulated_approximate_token_count": 5226, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2018-07-27 08:09:53, ended at 2018-07-27 09:18:56\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low grade squamous intraepithelial lesion on cervical Papanicolaou smear\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-27, presumably until 2019-02-15, with intended 1 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) every bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 15.6 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 265.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 41.3 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 15:14:21, ended at 2019-02-15 15:46:51\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-15, presumably until 2019-02-20, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-20, presumably until 2019-03-01, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-03-01, presumably until 2019-03-07, with intended 1 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-05-30, presumably until 2019-10-18, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER SKIN EVERY EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-28 00:00:00, ended at 2019-08-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-04 00:00:00, ended at 2019-09-04 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-06 11:31:00, ended at 2019-09-06 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation on X-ray examination made elsewhere, written report\n\n### Condition\n- Mammographic calcification of breast\n- Mammographic microcalcification of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-12 12:25:00, ended at 2019-09-12 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in upper inner quadrant of right breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-12, presumably until 2019-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-09-24, presumably until 2019-11-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-11-07, presumably until 2020-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-01-08, presumably until 2020-02-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-07, presumably until 2020-01-21, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER THE SKIN EVERY EVENING\n- atorvastatin 40 MG Oral Tablet, started on 2020-01-07, presumably until 2020-07-13, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 15:09:17, ended at 2020-01-21 15:59:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.0 (percent)\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Essential hypertension\n- Mild nonproliferative retinopathy of left eye due to diabetes mellitus\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-05-20, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-21, presumably until 2020-01-28, with intended 3 refill(s). Instructions: 24 Units by abdominal subcutaneous route AM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-02-04, presumably until 2020-02-04, with intended 1 refill(s). Instructions: inject 100 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-02-28, presumably until 2020-04-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-04-13, presumably until 2020-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-07-13, presumably until 2021-01-16, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-06 20:40:00, ended at 2020-10-06 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-30 11:10:00, ended at 2020-10-30 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-12 00:00:00, ended at 2020-11-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Lump in upper inner quadrant of right breast\n- Lump in upper outer quadrant of right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-11-12, presumably until 2020-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-13 12:00:00, ended at 2020-11-13 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 07:03:00, ended at 2020-12-02 09:27:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 09:28:00, ended at 2020-12-02 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Disorder of breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-09 15:16:28, ended at 2020-12-09 15:58:22\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including ultrasound guidance\n\n### Condition\n- Benign neoplasm of right breast\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-12-31 00:00:00, ended at 2020-12-31 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2020-12-31, presumably until 2020-12-31\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-12-31, presumably until 2020-12-31\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2020-12-31, presumably until 2020-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-01-16, presumably until 2022-02-18, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-27 08:09:53, ended at 2018-07-27 09:18:56\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low grade squamous intraepithelial lesion on cervical Papanicolaou smear\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-27, presumably until 2019-02-15, with intended 1 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) every bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 15.6 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 265.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 41.3 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 15:14:21, ended at 2019-02-15 15:46:51\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-15, presumably until 2019-02-20, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-20, presumably until 2019-03-01, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-03-01, presumably until 2019-03-07, with intended 1 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-05-30, presumably until 2019-10-18, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER SKIN EVERY EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-28 00:00:00, ended at 2019-08-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-04 00:00:00, ended at 2019-09-04 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-06 11:31:00, ended at 2019-09-06 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation on X-ray examination made elsewhere, written report\n\n### Condition\n- Mammographic calcification of breast\n- Mammographic microcalcification of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-12 12:25:00, ended at 2019-09-12 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in upper inner quadrant of right breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-12, presumably until 2019-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-09-24, presumably until 2019-11-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-11-07, presumably until 2020-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-01-08, presumably until 2020-02-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-07, presumably until 2020-01-21, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER THE SKIN EVERY EVENING\n- atorvastatin 40 MG Oral Tablet, started on 2020-01-07, presumably until 2020-07-13, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 15:09:17, ended at 2020-01-21 15:59:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.0 (percent)\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Essential hypertension\n- Mild nonproliferative retinopathy of left eye due to diabetes mellitus\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-05-20, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-21, presumably until 2020-01-28, with intended 3 refill(s). Instructions: 24 Units by abdominal subcutaneous route AM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-02-04, presumably until 2020-02-04, with intended 1 refill(s). Instructions: inject 100 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-02-28, presumably until 2020-04-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-04-13, presumably until 2020-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-07-13, presumably until 2021-01-16, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-06 20:40:00, ended at 2020-10-06 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-30 11:10:00, ended at 2020-10-30 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-12 00:00:00, ended at 2020-11-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Lump in upper inner quadrant of right breast\n- Lump in upper outer quadrant of right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-11-12, presumably until 2020-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-13 12:00:00, ended at 2020-11-13 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 07:03:00, ended at 2020-12-02 09:27:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 09:28:00, ended at 2020-12-02 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Disorder of breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-09 15:16:28, ended at 2020-12-09 15:58:22\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including ultrasound guidance\n\n### Condition\n- Benign neoplasm of right breast\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-12-31 00:00:00, ended at 2020-12-31 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2020-12-31, presumably until 2020-12-31\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-12-31, presumably until 2020-12-31\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2020-12-31, presumably until 2020-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-01-16, presumably until 2022-02-18, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "1668150d2b3e770bfb3911310bd351686f588bb3374f134c775b7773e328fad2", "prompt_hash": "bbe34b3915b9e52bd352e98edc3595d1d8fb8cb6acc58acfa8e10c22b8962d7a", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115967868, "visit_occurrence_id": 45095824, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2011-08-30 00:00:00", "visit_end_datetime": "2011-08-30 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2009-07-11 13:00:00", "patient_last_visit_date": "2021-07-02 00:00:00", "end_obs_date": "2012-08-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 5721, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3e234eef2f4784129299218fc963ede935b7b9ed6a95e0bf1129d432342fe88c", "prompt_hash": "d263a518d47a140ae65e47c1cfb29b9fcce48b95d6253a4dd4eb197c281dc263", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115967924, "visit_occurrence_id": 85358796, "death_date": null, "visit_concept_name": "Hospital", "visit_start_datetime": "2016-04-24 00:00:00", "visit_end_datetime": "2016-04-24 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n", "approximate_token_count": 99, "patient_first_visit_date": "2014-10-03 14:30:00", "patient_last_visit_date": "2018-07-08 11:13:00", "end_obs_date": "2017-04-24", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 1, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 4295, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-03 14:30:00, ended at 2014-10-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary malignant neoplasm of rectosigmoid junction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 12:12:00, ended at 2014-10-13 14:02:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- ranitidine 150 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- sucralfate 1000 MG Oral Tablet, through Oral route, presumably until 2015-03-07, with intended 0 refill(s). Instructions: take 1 g by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-13 14:03:00, ended at 2014-10-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-02 13:32:00, ended at 2014-11-02 23:59:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-03 00:00:00, ended at 2014-11-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-17 00:00:00, ended at 2015-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 12:36:00, ended at 2015-02-02 14:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Neoplasm defined only by topography: Rectum, NOS\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-02-02, presumably until 2015-02-03, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-02 14:30:00, ended at 2015-02-02 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of rectum\n- Digestive symptom\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-07 10:30:00, ended at 2015-03-07 13:29:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day.\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2015-03-30, with intended 0 refill(s). Instructions: take 40 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-03-13, presumably until 2015-03-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n\n### Condition\n- Primary malignant neoplasm of rectum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- ertapenem 1000 MG Injection, started on 2015-03-15, presumably until 2015-03-15\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-15\n- midazolam 1 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-03-15, presumably until 2015-03-15\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-03-15, presumably until 2015-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-03-15 07:36:00, ended at 2015-03-17 13:47:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.49 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Glucose [Mass/volume] in Blood: 131 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Other anterior resection of rectum\n- Anastomosis of large intestine to large intestine\n\n### Condition\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of rectum\n- Gastroesophageal reflux disease\n- Intestinal disaccharidase deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-03-15, presumably until 2015-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2015-03-16, presumably until 2015-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-03-16, presumably until 2015-03-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-03-16, presumably until 2015-03-16\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-17\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-15\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-03-15, presumably until 2015-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-03-15, presumably until 2015-03-15\n- alvimopan 12 MG Oral Capsule, through Oral route, started on 2015-03-15, presumably until 2015-03-16\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-03-16, presumably until 2015-09-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 13:08:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.094\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 11:06:42, ended at 2015-09-21 11:41:05\nThe patient in this visit was 56 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of rectum\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2015-09-21, presumably until 2015-09-21, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n- prochlorperazine 10 MG Oral Tablet, started on 2015-06-14, presumably until 2015-06-14, with intended 0 refill(s)\n- psyllium 6000 MG Powder for Oral Suspension, through Oral route, started on 2015-09-21, presumably until 2015-09-21. Instructions: take 1 Packet by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2016-03-11, presumably until 2016-03-11, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-04-24, presumably until 2016-04-24\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "2f8946aab9035e9ecc732786397cf833bf4a5cccd6d30e12f3f10b40affe0d8c", "prompt_hash": "34524714050c9159f02bbbaf2c85e62ea74a723e4c16e6799bdc5162d74b81c4", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115967988, "visit_occurrence_id": 68382974, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-01-09 08:30:00", "visit_end_datetime": "2015-01-09 23:59:00", "visit_length_in_hours": 15.483333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 93, "patient_first_visit_date": "2013-10-15 08:07:00", "patient_last_visit_date": "2016-08-15 13:04:00", "end_obs_date": "2016-01-09", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 33, "cumulated_visit_num": 33, "cumulated_approximate_token_count": 7035, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e2d5239cb3a08a651b0636502e6d6c8f7b26964641dcdfd990575ccdf9f4654c", "prompt_hash": "f3d8af4401a85b10680aad8646e4503265b3e53156f2fa88f5b8fdbcb050ee52", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115968044, "visit_occurrence_id": 40081595, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2010-07-05 08:11:00", "visit_end_datetime": "2010-07-05 23:59:00", "visit_length_in_hours": 15.8, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 114, "patient_first_visit_date": "2008-10-07 00:00:00", "patient_last_visit_date": "2011-07-05 08:37:00", "end_obs_date": "2011-07-05", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 9, "cumulated_visit_num": 9, "cumulated_approximate_token_count": 4322, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Asthma within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c254a001ee48bb21c36a773eae51b70e69d01534063de796472cacfa88740c7d", "prompt_hash": "28c65b30a69f5a37cf18399a75778ddce5af6fa0524053385c77b1dd615c465d", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
